MOREPENLAB vs NGLFINE: Stock Comparison

MOREPEN LAB. vs NGL FINE CHEMUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

MOREPEN LAB. is the larger company by market capitalisation. MOREPEN LAB. shows lower leverage, while NGL FINE CHEM shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

MOREPENLAB leads 2; NGLFINE leads 11 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

MOREPENLABNGLFINE

Valuation lens

What price are you paying?

Market CapContext only
₹6,230 Cr
₹1,804 Cr
P/E RatioNGLFINE has the lower reading
44.1x
30.41x
P/B RatioMOREPENLAB has the lower reading
4.96x
5.28x
EPSNGLFINE has the higher reading
₹0.99
₹29.78
Book ValueContext only
₹22.76
₹532.9
Dividend YieldNGLFINE has the higher reading
0%
0.07%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
MOREPENLAB is the larger company
₹6,230 Cr vs ₹1,804 Cr
P/E Ratio
NGLFINE has a lower P/E
30.41x vs 44.1x
P/B Ratio
MOREPENLAB has a lower P/B
4.96x vs 5.28x
EPS
NGLFINE has higher earnings per share
₹29.78 vs ₹0.99
Dividend Yield
NGLFINE has a higher dividend yield
0.07% vs 0%
Revenue Growth (TTM YoY)
NGLFINE has faster revenue growth
57.2% vs 4%
EPS Growth (TTM YoY)
NGLFINE has faster EPS growth
1,539.8% vs -18.9%
Qtr Sales Growth
NGLFINE has stronger quarterly sales growth
1.79% vs -5.1%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricMOREPENLABNGLFINE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricMOREPENLABNGLFINE
Live Price₹113.74₹2,907.5
Day Change-3.16%-1.13%
Volume1.76 Cr7,107
52-Week High₹118.55₹3,602
52-Week Low₹33.05₹1,271
Distance from 52W High-4.06%-19.28%

Valuation

MetricMOREPENLABNGLFINE
Market Cap₹6,230 Cr₹1,804 Cr
P/E Ratio44.1x30.41x
P/B Ratio4.96x5.28x
EPS₹0.99₹29.78
Book Value₹22.76₹532.9
Dividend Yield0%0.07%

Growth

MetricMOREPENLABNGLFINE
Revenue Growth (TTM YoY)4%57.2%
EPS Growth (TTM YoY)-18.9%1,539.8%
Qtr Sales Growth-5.1%1.79%
Qtr Profit Growth-4.26%11.83%

Profitability & Leverage

MetricMOREPENLABNGLFINE
ROE7.61%13.01%
ROCE7.71%10.54%
Net Margin5.25%9.59%
Operating Margin7.55%12.08%
Debt to Equity0.16x0.34x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricMOREPENLABNGLFINE
Promoter Holding35.65%72.49% 0.25 pp
FII Holding1.46% 0.12 pp0.05% 0.02 pp
DII Holding1.28% 0.03 pp0.02% 0.02 pp
Public Holding61.59% 0.09 pp27.43% 0.19 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: MOREPEN LAB. and NGL FINE CHEM.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.